Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age Journal Article


Authors: Radosa, J. C.; Eaton, A.; Stempel, M.; Khander, A.; Liedtke, C.; Solomayer, E. F.; Karsten, M.; Pilewskie, M.; Morrow, M.; King, T. A.
Article Title: Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age
Abstract: Background: Triple-negative breast cancer (TNBC) subtype and young patient age are both associated with an increased risk of local recurrence (LR) and distant recurrence (DR). In young women with TNBC, it is unclear whether subtype or patient age is driving prognosis. Methods: Patients treated for primary TNBC from 1998 to 2011 were identified from the breast surgery database. Clinicopathologic characteristics, treatment, and outcomes were compared between patients <40 and ≥40 years of age at diagnosis. Multivariate models were used to identify factors independently associated with LR and DR. Results: Among 1930 patients with TNBC, 289 (15 %) were <40 and 1641 (85 %) were ≥40 years of age at diagnosis. Younger patients were more likely to present with higher stage disease and more likely to receive mastectomy (p < 0.01), axillary node dissection (p < 0.01), and chemotherapy (p < 0.01). At a median follow-up of 74 (0–201.1) months, there was no difference in LR or disease-free survival (DFS) by age group [5-year LR = 3.9 % (95 % confidence interval (CI) 1.5–6.2) vs. 4.5 % (95 % CI 3.5–5.6) and 5-year DFS = 75.3 % (95 % CI 70.2–80.7) vs. 77.7 % (95 % CI 75.6–79.8), p = 0.94] in patients aged <40 and ≥40 years, respectively. On multivariate analysis, larger tumor size, lymphovascular invasion, and nodal positivity were associated with increased risk of DR. Age and type of surgery were not significantly associated with either outcome. Conclusions: Young age at diagnosis is not an independent risk factor for LR or DR in patients with TNBC. © 2016, Society of Surgical Oncology.
Journal Title: Annals of Surgical Oncology
Volume: 24
Issue: 3
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2017-03-01
Start Page: 698
End Page: 704
Language: English
DOI: 10.1245/s10434-016-5631-3
PROVIDER: scopus
PUBMED: 27783163
PMCID: PMC5408739
DOI/URL:
Notes: Article -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    772 Morrow
  2. Tari King
    186 King
  3. Anne Austin Eaton
    122 Eaton
  4. Michelle Moccio Stempel
    153 Stempel
  5. Melissa Louise Pilewskie
    112 Pilewskie
  6. Julia Caroline Radosa
    4 Radosa